Cynata Therapeutics adds new sitefor MEND clinical trialMay 30, 2022LATEST NEWS Australian cell therapy company Cynata Therapeutics (ASX:CYP) has announced that St George Hospital in Sydney is now a participatingsite and is seeking to recruit patients in the MEND clinical trial. The pilot, open-label, randomised controlled clinical trial is investigating the earlyefficacy of CYP-001 in adults admitted to intensive care with respiratory failure.Cynata's chief medical officer Dr Jolanta Airey said,& "We are very pleased St GeorgeHospital is non the MEND trial We nassed the halfwavhe trial
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 23813 | 3 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |